Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users

Jichuan Wang; Brian C. Kelly; Brenda M. Booth; Russel S. Falck; Carl Leukefeld; Robert G. Carlson

doi:10.1016/j.addbeh.2009.08.003

Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users

Jichuan Wang, Brian C. Kelly, Brenda M. Booth, Russel S. Falck, Carl Leukefeld, Robert G. Carlson

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Abstract

The purpose of this study is to examine the factorial structure of the Brief Symptom Inventory 18 (BSI-18) and test its measurement invariance among different drug using populations. A total sample of 710 drug users was recruited using respondent-drive sampling (RDS) from three states: Ohio (n = 248), Arkansas (n = 237), and Kentucky (n = 225). The results of confirmatory factor analysis (CFA) show: 1) the BSI-18 has a three-factor structure (somatization, depression, and anxiety) with an underlying second-order factor (global severity index of distress); and 2) its factorial structure and metric (factor loadings) are invariant across populations under study. However, the scalars (intercepts) of the BSI-18 items are not invariant, and the means of the latent factors also varied across populations. Our findings provide evidence of a valid factorial structure of the BSI-18 that can be readily applied to studying drug using populations.

Original language	English
Pages (from-to)	23-29
Number of pages	7
Journal	Addictive Behaviors
Volume	35
Issue number	1
DOIs	https://doi.org/10.1016/j.addbeh.2009.08.003
State	Published - Jan 2010

Bibliographical note

Funding Information:
This research was supported by the National Institute on Drug Abuse grant numbers R01 DA15363 and R01 DA14340 . The views expressed in this paper do not necessarily reflect those of the National Institute on Drug Abuse or any other governing agency.

Funding

This research was supported by the National Institute on Drug Abuse grant numbers R01 DA15363 and R01 DA14340 . The views expressed in this paper do not necessarily reflect those of the National Institute on Drug Abuse or any other governing agency.

Funders	Funder number
National Institute on Drug Abuse	R01 DA14340, R01DA015363

Keywords

BSI-18
CFA model
Drug users
Measurement invariance
Psychological distress

ASJC Scopus subject areas

Medicine (miscellaneous)
Clinical Psychology
Toxicology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.addbeh.2009.08.003

Cite this

@article{3b58f97fdc9042c2870d6c2f7b980adc,

title = "Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users",

abstract = "The purpose of this study is to examine the factorial structure of the Brief Symptom Inventory 18 (BSI-18) and test its measurement invariance among different drug using populations. A total sample of 710 drug users was recruited using respondent-drive sampling (RDS) from three states: Ohio (n = 248), Arkansas (n = 237), and Kentucky (n = 225). The results of confirmatory factor analysis (CFA) show: 1) the BSI-18 has a three-factor structure (somatization, depression, and anxiety) with an underlying second-order factor (global severity index of distress); and 2) its factorial structure and metric (factor loadings) are invariant across populations under study. However, the scalars (intercepts) of the BSI-18 items are not invariant, and the means of the latent factors also varied across populations. Our findings provide evidence of a valid factorial structure of the BSI-18 that can be readily applied to studying drug using populations.",

keywords = "BSI-18, CFA model, Drug users, Measurement invariance, Psychological distress",

author = "Jichuan Wang and Kelly, \{Brian C.\} and Booth, \{Brenda M.\} and Falck, \{Russel S.\} and Carl Leukefeld and Carlson, \{Robert G.\}",

note = "Funding Information: This research was supported by the National Institute on Drug Abuse grant numbers R01 DA15363 and R01 DA14340 . The views expressed in this paper do not necessarily reflect those of the National Institute on Drug Abuse or any other governing agency.",

year = "2010",

month = jan,

doi = "10.1016/j.addbeh.2009.08.003",

language = "English",

volume = "35",

pages = "23--29",

number = "1",

}

TY - JOUR

T1 - Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users

AU - Wang, Jichuan

AU - Kelly, Brian C.

AU - Booth, Brenda M.

AU - Falck, Russel S.

AU - Leukefeld, Carl

AU - Carlson, Robert G.

N1 - Funding Information: This research was supported by the National Institute on Drug Abuse grant numbers R01 DA15363 and R01 DA14340 . The views expressed in this paper do not necessarily reflect those of the National Institute on Drug Abuse or any other governing agency.

PY - 2010/1

Y1 - 2010/1

N2 - The purpose of this study is to examine the factorial structure of the Brief Symptom Inventory 18 (BSI-18) and test its measurement invariance among different drug using populations. A total sample of 710 drug users was recruited using respondent-drive sampling (RDS) from three states: Ohio (n = 248), Arkansas (n = 237), and Kentucky (n = 225). The results of confirmatory factor analysis (CFA) show: 1) the BSI-18 has a three-factor structure (somatization, depression, and anxiety) with an underlying second-order factor (global severity index of distress); and 2) its factorial structure and metric (factor loadings) are invariant across populations under study. However, the scalars (intercepts) of the BSI-18 items are not invariant, and the means of the latent factors also varied across populations. Our findings provide evidence of a valid factorial structure of the BSI-18 that can be readily applied to studying drug using populations.

AB - The purpose of this study is to examine the factorial structure of the Brief Symptom Inventory 18 (BSI-18) and test its measurement invariance among different drug using populations. A total sample of 710 drug users was recruited using respondent-drive sampling (RDS) from three states: Ohio (n = 248), Arkansas (n = 237), and Kentucky (n = 225). The results of confirmatory factor analysis (CFA) show: 1) the BSI-18 has a three-factor structure (somatization, depression, and anxiety) with an underlying second-order factor (global severity index of distress); and 2) its factorial structure and metric (factor loadings) are invariant across populations under study. However, the scalars (intercepts) of the BSI-18 items are not invariant, and the means of the latent factors also varied across populations. Our findings provide evidence of a valid factorial structure of the BSI-18 that can be readily applied to studying drug using populations.

KW - BSI-18

KW - CFA model

KW - Drug users

KW - Measurement invariance

KW - Psychological distress

UR - https://www.scopus.com/pages/publications/70349792230

UR - https://www.scopus.com/inward/citedby.url?scp=70349792230&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2009.08.003

DO - 10.1016/j.addbeh.2009.08.003

M3 - Article

C2 - 19733442

AN - SCOPUS:70349792230

SN - 0306-4603

VL - 35

SP - 23

EP - 29

JO - Addictive Behaviors

JF - Addictive Behaviors

IS - 1

ER -

Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this